Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRTC NASDAQ:PRCT NASDAQ:RXST NASDAQ:SLNO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$179.82-0.7%$156.38$55.92▼$187.57$5.78B1.1376,581 shs232,437 shsPRCTPROCEPT BioRobotics$37.14-3.9%$46.77$36.90▼$103.81$2.07B1.03891,441 shs1.09 million shsRXSTRxSight$9.31-1.2%$8.41$6.32▼$57.53$380.97M1.171.11 million shs733,010 shsSLNOSoleno Therapeutics$53.62-5.5%$77.05$41.50▼$90.32$2.85B-2.711.62 million shs3.25 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies0.00%-0.68%+11.98%+24.18%+134.72%PRCTPROCEPT BioRobotics0.00%-8.70%-10.70%-38.51%-54.21%RXSTRxSight0.00%+4.72%+10.44%-33.92%-83.06%SLNOSoleno Therapeutics0.00%-23.15%-25.14%-31.39%+1.48%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$179.82-0.7%$156.38$55.92▼$187.57$5.78B1.1376,581 shs232,437 shsPRCTPROCEPT BioRobotics$37.14-3.9%$46.77$36.90▼$103.81$2.07B1.03891,441 shs1.09 million shsRXSTRxSight$9.31-1.2%$8.41$6.32▼$57.53$380.97M1.171.11 million shs733,010 shsSLNOSoleno Therapeutics$53.62-5.5%$77.05$41.50▼$90.32$2.85B-2.711.62 million shs3.25 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies0.00%-0.68%+11.98%+24.18%+134.72%PRCTPROCEPT BioRobotics0.00%-8.70%-10.70%-38.51%-54.21%RXSTRxSight0.00%+4.72%+10.44%-33.92%-83.06%SLNOSoleno Therapeutics0.00%-23.15%-25.14%-31.39%+1.48%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRTCiRhythm Technologies 3.00Buy$163.82-8.90% DownsidePRCTPROCEPT BioRobotics 2.89Moderate Buy$73.2297.15% UpsideRXSTRxSight 1.92Reduce$10.007.41% UpsideSLNOSoleno Therapeutics 3.08Buy$115.09114.64% UpsideCurrent Analyst Ratings BreakdownLatest RXST, IRTC, SLNO, and PRCT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/10/2025SLNOSoleno TherapeuticsLifesci CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy9/8/2025RXSTRxSightZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold9/2/2025PRCTPROCEPT BioRoboticsOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$60.008/28/2025IRTCiRhythm TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$180.00 ➝ $193.008/27/2025SLNOSoleno TherapeuticsGuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$106.008/21/2025IRTCiRhythm TechnologiesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$167.00 ➝ $183.008/20/2025IRTCiRhythm TechnologiesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$200.008/20/2025SLNOSoleno TherapeuticsWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$123.008/18/2025SLNOSoleno TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$100.00 ➝ $110.008/8/2025RXSTRxSightUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$16.00 ➝ $8.008/8/2025RXSTRxSightStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRTCiRhythm Technologies$591.84M9.76N/AN/A$2.90 per share62.01PRCTPROCEPT BioRobotics$224.50M9.20N/AN/A$7.71 per share4.82RXSTRxSight$139.93M2.72N/AN/A$6.98 per share1.33SLNOSoleno TherapeuticsN/AN/AN/AN/A$5.68 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRTCiRhythm Technologies-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)PRCTPROCEPT BioRobotics-$91.41M-$1.55N/AN/AN/A-30.60%-23.73%-17.34%10/27/2025 (Estimated)RXSTRxSight-$27.45M-$0.80N/AN/AN/A-21.93%-11.56%-10.31%11/6/2025 (Estimated)SLNOSoleno Therapeutics-$175.85M-$4.14N/AN/AN/AN/A-73.74%-56.67%11/5/2025 (Estimated)Latest RXST, IRTC, SLNO, and PRCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Guidance UpdateRXSTRxSight-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 million8/6/2025Q2 2025PRCTPROCEPT BioRobotics-$0.41-$0.35+$0.06-$0.35$75.67 million$79.18 million8/6/2025Q2 2025SLNOSoleno Therapeutics-$0.53-$0.09+$0.44-$0.09$3.91 million$32.66 million7/31/2025Q2 2025IRTCiRhythm Technologies-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRTCiRhythm TechnologiesN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/ASLNOSoleno TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRTCiRhythm Technologies6.255.024.88PRCTPROCEPT BioRobotics0.139.217.86RXSTRxSightN/A13.9312.70SLNOSoleno Therapeutics0.2115.1315.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRTCiRhythm TechnologiesN/APRCTPROCEPT BioRobotics89.46%RXSTRxSight78.78%SLNOSoleno Therapeutics97.42%Insider OwnershipCompanyInsider OwnershipIRTCiRhythm Technologies0.68%PRCTPROCEPT BioRobotics17.40%RXSTRxSight9.57%SLNOSoleno Therapeutics6.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRTCiRhythm Technologies2,00032.13 million31.91 millionOptionablePRCTPROCEPT BioRobotics43055.64 million45.96 millionOptionableRXSTRxSight22040.92 million37.00 millionOptionableSLNOSoleno Therapeutics3053.15 million49.74 millionOptionableRXST, IRTC, SLNO, and PRCT HeadlinesRecent News About These CompaniesWhat is Lifesci Capital's Estimate for SLNO Q3 Earnings?September 14 at 6:34 AM | marketbeat.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 13 at 3:15 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.- SLNOSeptember 13 at 2:45 PM | prnewswire.comSoleno Therapeutics (NASDAQ:SLNO) Upgraded to Strong-Buy at Lifesci CapitalSeptember 13 at 7:21 AM | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Down 8.9% - What's Next?September 12 at 3:13 PM | marketbeat.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 12 at 3:00 PM | prnewswire.comOptimize Financial Inc Makes New Investment in Soleno Therapeutics, Inc. $SLNOSeptember 12 at 6:41 AM | marketbeat.comWoodline Partners LP Grows Stock Position in Soleno Therapeutics, Inc. $SLNOSeptember 12 at 6:41 AM | marketbeat.comFred Alger Management LLC Has $2.89 Million Holdings in Soleno Therapeutics, Inc. $SLNOSeptember 12 at 5:19 AM | marketbeat.comSOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the FirmSeptember 11, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens BermanSeptember 11, 2025 | globenewswire.comAre Legal Probes Shaping Trust in Soleno Therapeutics’ (SLNO) Drug Pipeline and Investor Relations?September 11, 2025 | finance.yahoo.comSoleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerSeptember 11, 2025 | zacks.comSoleno Therapeutics (SLNO) Falls Hard on Patient DeathSeptember 11, 2025 | msn.comSoleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs MuraSeptember 10, 2025 | businesswire.comSLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law FirmSeptember 10, 2025 | businesswire.comSoleno Therapeutics stock falls after patient death reportSeptember 10, 2025 | in.investing.comUnpacking the Latest Options Trading Trends in Soleno TherapeuticsSeptember 10, 2025 | benzinga.comSoleno drops on death of patient treated with Vykat XRSeptember 10, 2025 | msn.comSoleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details InsideSeptember 10, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 10, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRXST, IRTC, SLNO, and PRCT Company DescriptionsiRhythm Technologies NASDAQ:IRTC$179.82 -1.21 (-0.67%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$177.00 -2.82 (-1.57%) As of 09/12/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.PROCEPT BioRobotics NASDAQ:PRCT$37.14 -1.50 (-3.88%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$37.35 +0.21 (+0.58%) As of 06:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.RxSight NASDAQ:RXST$9.31 -0.11 (-1.17%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$9.28 -0.03 (-0.32%) As of 05:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Soleno Therapeutics NASDAQ:SLNO$53.62 -3.10 (-5.47%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$53.06 -0.56 (-1.04%) As of 05:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
